Hong Jiang1, Lina Pei2, Nannan Liu3, Junsheng Li1, Zhengrong Li1, Shumei Zhang1. 1. a Department of Pharmacy , Linyi People's Hospital , Linyi, Shandong , P.R. China . 2. b Department of Pharmacy , People's Hospital of Rizhao , Rizhao, Shandong , P.R. China , and. 3. c Department of Pharmacy , No. 4 People's Hospital of Zibo , Zibo, Shandong , P.R. China.
Abstract
PURPOSE: Gastric carcinoma is one of the most common cancers and the second most frequent cause of cancer-related deaths. The aim of this study was to prepare and characterize etoposide-loaded nanostructured lipid carriers (ETP-NLCs) and evaluate their antitumor activity in vitro and in vivo. METHODS: Novel ETP-NLCs were constructed. The physicochemical properties of the ETP-NLCs were investigated by particle-size analysis, zeta potential measurement, drug loading, drug entrapment efficiency, stability and in vitro drug release behavior. In vitro cytotoxicity against human gastric cancer cells (SGC7901 cells) was investigated, and in vivo antitumor of NLCs was evaluated on mice bearing SGC7901 cells xenografts. RESULTS: ETP-NLCs have a narrow size distribution at 91 nm, a zeta potential value of +23.1 mV, high drug entrapment efficiency of 78%. The drug release of ETP-NLCs exhibited a sustained behavior, which made it an ideal vehicle for drug delivery. Furthermore, ETP-NLCs could significantly enhance in vitro cytotoxicity and in vivo antitumor effect against SGC7901 cells and gastric cancer animal model compared to the free drug. CONCLUSION: The results demonstrated that the NLCs might be a promising nanomedicine for the treatment of gastric carcinoma.
PURPOSE:Gastric carcinoma is one of the most common cancers and the second most frequent cause of cancer-related deaths. The aim of this study was to prepare and characterize etoposide-loaded nanostructured lipid carriers (ETP-NLCs) and evaluate their antitumor activity in vitro and in vivo. METHODS: Novel ETP-NLCs were constructed. The physicochemical properties of the ETP-NLCs were investigated by particle-size analysis, zeta potential measurement, drug loading, drug entrapment efficiency, stability and in vitro drug release behavior. In vitro cytotoxicity against humangastric cancer cells (SGC7901 cells) was investigated, and in vivo antitumor of NLCs was evaluated on mice bearing SGC7901 cells xenografts. RESULTS: ETP-NLCs have a narrow size distribution at 91 nm, a zeta potential value of +23.1 mV, high drug entrapment efficiency of 78%. The drug release of ETP-NLCs exhibited a sustained behavior, which made it an ideal vehicle for drug delivery. Furthermore, ETP-NLCs could significantly enhance in vitro cytotoxicity and in vivo antitumor effect against SGC7901 cells and gastric cancer animal model compared to the free drug. CONCLUSION: The results demonstrated that the NLCs might be a promising nanomedicine for the treatment of gastric carcinoma.
Entities:
Keywords:
Gastric cancer therapy; in vitro cytotoxicity; in vivo drug delivery; nanostructured lipid carriers
Authors: Gustavo Henrique Rodrigues da Silva; Ludmilla David de Moura; Fabíola Vieira de Carvalho; Gabriela Geronimo; Talita Cesarim Mendonça; Fernando Freitas de Lima; Eneida de Paula Journal: Molecules Date: 2021-11-17 Impact factor: 4.411
Authors: Tahereh Mirzaei; Seyed Amir Sheikholeslami; Ahmad Bereimipour; Arsalan Jalili; Alireza Zali; Sheida Sharbati; Vahid Kaveh; Sina Salari Journal: J Family Med Prim Care Date: 2022-06-30
Authors: Giuseppina Ioele; Martina Chieffallo; Maria Antonietta Occhiuzzi; Michele De Luca; Antonio Garofalo; Gaetano Ragno; Fedora Grande Journal: Molecules Date: 2022-08-25 Impact factor: 4.927